Advice from the TOP: Apollo Endosurgery CEO Todd Newton
Austin, Texas – January 28, 2015 – PTV Healthcare Capital today launched the third video in their new video series, Advice from the TOP. The video features Apollo Endosurgery Chief Executive Officer Todd Newton on the challenges of being the CEO of a growing startup, what it’s like to work with PTV, and the best advice he’s ever gotten.
Mr. Newton is a seasoned executive who joined Apollo Endosurgery as Chief Executive Officer and as a member of the board of directors in 2014. Prior to Apollo he spent five years at ArthroCare Corporation, where he served as Executive Vice President, Chief Financial Officer, and Chief Operating Officer. During his tenure at ArthroCare, Mr. Newton helped to stabilize operations, which lead to the Company’s achievement of its highest-ever levels of profitability and cash flow and its acquisition by Smith & Nephew for $1.7 billion.
Prior to his leadership at ArthroCare, Mr. Newton served in a number of executive officer roles for Synenco Energy, Inc., including President and Chief Executive Officer. He began his career at Deloitte & Touche LLP, where he served in various roles from 1984 to 2004, including Partner.
“There’s going to always be things that you encounter that are going to be new experiences for you,” says Newton, in the video. “Nothing is going to happen exactly the way that you plan. And it’s really important to have someone that you can collaborate with, someone that can be an advisor, a business partner, that can help you work through those issues that you’re undoubtedly going to run into.”
The Advice from the TOP series, which launched in December of last year, features PTV CEOs and Senior Advisors as well as other industry thought leaders offering insight and advice to entrepreneurs in the healthcare industry and reflecting on their experiences partnering with PTV.
PTV is a healthcare venture capital and growth equity firm dedicated to enabling healthcare entrepreneurs and global innovation. It is comprised of a highly collaborative team of professionals, deeply experienced as investors and operators of life science companies. PTV focuses on mid-to-late stage companies with comparatively low technical, regulatory, and financial risk that are “with the grain” of healthcare economics – improving patient outcomes while decreasing costs – in markets with significant unmet clinical needs.